Farma

Kalleklovn
20.09.2018 kl 08:45 6421

Styreleder Hans Peter Bøhn full tegner for 1,200,000 kroner, som dere kan lese nedenfor så er han financial analyst in Fondsfinans and From 2012 he has been manager of the nonprofit "Svanhild og Arne Musts Fond for Medisinsk Forskning.(google gjerne Arne Must)

Som jeg har nevnt tidligere så var nok denne emisjonen ønsket av de største aksjonærene fordi dem ser den enorme verdiøkningen PCIB kan få de neste årene.



Hans Peter Bøhn (born 1955), Chairman Dr. Bøhn is a Norwegian citizen with a medical degree. He started his pharmaceutical industry career as medical adviser in Nycomed Imaging. Over the ensuing 12 years he gained broad experience from management positions in the pharmaceutical industry within drug safety, international marketing and operations and clinical research as well as gaining a post-graduate Diploma of Pharmaceutical Medicine. After the years in the industry he joined Fondsfinans as a financial analyst covering the life science sector. From 2012 he has been manager of the nonprofit "Svanhild og Arne Musts Fond for Medisinsk Forskning" as well as serving as an independent adviser to among others the Research Council of Norway, the Norwegian Cancer Society, Innovation Norway, Oslo Cancer Cluster as well as a number of biotech start-up companies. He has been a Board member of PCI Biotech Holding ASA since 2015.






Underwriter Address NOK underwritten
Nyenburg Holding B.V. Beursplein 5, 1012 JW Amsterdam, the Netherlands 99 000 000
MP Pensjon PK Lakkegata 23, 0187 Oslo, Norway 90 000 000
Fondsavanse AS Haakon VIIs gate 2, 0161 Oslo, Norway 39 500 000
Norda ASA Stortingsgata 28, 0161 24 000 000
Verdipapirfondet First Globalt Fokus Bolette Brygge 1, 0252 Oslo, Norway 24 000 000
Myrlid AS Strandkaien 16, 5013 Bergen 20 000 000
Kistefos AS Dokkveien 1, 0250 Oslo, Norway 15 000 000
Altitude AS Holmenkollveien 133A, 0787 Oslo, Norway 12 000 000
Veslik AS c/o Koppang, Torjusbakken 19D, 0378 Oslo 7 500 000
Storebrand Norge Indeks Professor Kohts vei 9, 1366 Lysaker 7 500 000
TD Veen AS Eiganesveien 95, 4009 Stavanger, Norway 7 500 000
Wenaas Kapital AS Furulundvegen 7, 6386 Måndalen, Norway 6 000 000
Radiumhospitales Forskningsstiftelse Ullernchausséen 64, 0379 Oslo 5 000 000
L1 Capital Global Opportunities Master Fund
161A Shedden road, 1 Artillery Court, PO Box 10085, Grand Cayman KY1-1001, Cayman Islands
2 000 000
Stocken Invest AS* Stjerneveien 13, 0779 Oslo 1 000 000
Redigert 20.09.2018 kl 08:51

Rapportér innlegg

Vennligst skriv inn kommentar på hva du mener er upassende og trykk send. Dersom kommentar ikke er nødvendig, vennligst trykk send direkte.
E-postadressen brukes kun for å få kontakt med deg i forbindelse med advarselen.
E-postadressen brukes kun for å få kontakt med deg i forbindelse med advarselen.